Purchase Order N0025922P0238

The Defense Health Agency awarded a $745,185 firm fixed price purchase order to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. for 94 Aptima SARS-CoV-2 assay boxes containing 250 tests per box, 47 Aptima SARS-CoV-2 control boxes with five positive and five negative controls per box, and 235 Fusion specimen lysis tubes in 100 bags per box. The place of performance is in Marlborough, Massachusetts and the period of performance runs from February 17, 2022 through September 30, 2023....

The Defense Health Agency (DOD) awarded a $357,330 firm fixed price purchase order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division to provide 95 Aptima SARS-CoV-2 assay boxes containing 250 tests per box, 28 Aptima SARS-CoV-2 control boxes containing 5 positive and 5 negative controls per box, and 20 Fusion specimen lysis tubes containing 100 bags per box. The place of performance is Marlborough, Massachusetts and the period of performance is from January 24, 2022...

The Defense Health Agency (DOD) awarded a $320,542.72 delivery order contract to Gen-Probe Incorporated Gen-Probe Sales & Service, Inc. Division for APTIMA SARS-COV-2 ASSAY, EUA, 250-TEST. The firm fixed price contract has a period of performance starting on January 20, 2022 through February 18, 2022 and will be performed in Portsmouth, Virginia. Gen-Probe Incorporated will provide its APTIMA SARS-COV-2 ASSAY test kits, which have received Emergency Use Authorization from the U.S. Food and...

<p>The Defense Health Agency (DOD) awarded a $745,185 purchase order to Gen-Probe Incorporated Gen-Probe Sales &amp; Service, Inc. Division for APTIMA SARS-COV-2 ASSAY KITS. The firm fixed price contract will provide coronavirus COVID-19 testing kits to support national interest actions in Japan, with performance taking place from May 10, 2022 through June 1, 2022.</p>

This federal contract award to Gen-Probe Incorporated, a medical diagnostics company, was issued by the Defense Health Agency. The $552,691.20 firm fixed-price delivery order is for the APTIMA SARS-CoV-2 ASSAY, a COVID-19 testing kit under the Emergency Use Authorization (EUA). The contract has no set-aside designation and is scheduled for completion by September 30, 2022. Gen-Probe Incorporated holds several Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with...

This firm fixed-price purchase order was awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company, for the procurement of 250 APTIMA SARS-CoV-2 assay test kits, 30 APTIMA SARS-CoV-2 controls, and 76 Fusion specimen lysis tubes. The total potential value of the award is $239,790.00. The purchase order was not set aside and supports the government's Coronavirus COVID-19 response efforts. Gen-Probe Incorporated is a provider of molecular diagnostic testing...

The Defense Health Agency awarded a $2,300 firm fixed price delivery order contract to Gen-Probe Incorporated for COVID19 reagents. The contract has no set aside designation and requires performance in Marlborough, Massachusetts by March 23, 2021. Gen-Probe Sales &amp; Service, Inc. will perform as a division of Gen-Probe Incorporated. The contract was awarded on March 16, 2021 under the National Interest Action Code for Coronavirus COVID-19 in support of the Defense Health Agency's response...

The Department of the Army Medical Command awarded a $518,400 purchase order to Gen-Probe Incorporated Gen-Probe Sales &amp; Service, Inc. Division for reagents and assays in support of the Coronavirus COVID-19 national interest. The contract was awarded under the agency's $20 million Coronavirus program and will provide the requested products for use at the prime contractor's location in Marlborough, Massachusetts between April 6th and 17th, 2020. A firm fixed price was established for this...

The Defense Health Agency (DOD) awarded a $888,380 firm fixed price delivery order contract to Gen-Probe Incorporated Gen-Probe Sales &amp; Service, Inc. for COVID19 reagents. The contract has a period of performance from November 17, 2020 through March 12, 2021, with all work to be conducted by the prime contractor at its location in Marlborough, Massachusetts. This delivery order is likely associated with DHA's medical products procurement programs to support the COVID-19 response effort. No...

This is a firm fixed-price purchase order awarded by the Defense Health Agency to Gen-Probe Incorporated, a medical diagnostics company that produces molecular diagnostic testing systems and assays. The contract is for the delivery of APTIMA SARS-CoV-2 tests to detect COVID-19, with a potential value of $745,185.00 and a completion date of March 31, 2023. The contract is part of the agency's efforts to procure necessary medical supplies related to the Coronavirus COVID-19 national interest...